U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP), pledging to address what he calls inefficiencies and corruption within the system. Kennedy, a long-time vaccine skeptic and former vaccine injury lawyer, criticized the program’s “Vaccine Court” for failing to quickly and fairly compensate individuals harmed by vaccines.
In a post on X, Kennedy said he is working with Attorney General Pam Bondi to restore the program to its “original congressional intent,” arguing that its current structure unfairly positions the Department of Health and Human Services (HHS), which he leads, as the defendant rather than vaccine manufacturers.
This move continues Kennedy’s sweeping efforts to reshape U.S. vaccine and health policy. In June, he dismissed all 17 members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, replacing them with seven appointees, including figures with histories of questioning vaccine safety. One of these members previously earned significant fees as an expert witness against Merck’s Gardasil vaccine, a case in which Kennedy played a key role.
Kennedy is also reportedly considering removing members of another influential health advisory panel, the U.S. Preventive Services Task Force. His tenure at HHS has intensified scrutiny due to his longstanding promotion of vaccine skepticism, including discredited claims linking vaccines to autism and false statements about fetal cells in the measles vaccine.
The announcement comes amid one of the worst U.S. measles outbreaks in decades, further fueling debate over vaccine safety, public health policy, and Kennedy’s leadership approach.


New Zealand Moves to Ban Social Media for Children Under 16
Israeli Strikes Kill Four in Gaza, Including Two Children
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Trump Imposes New US Tariffs on Drone Imports Over National Security Concerns
Milei Threatens Falkland Oil Firms With Sanctions
Iran’s Hormuz Oil Pressure Fades as Gulf Crude Flows Continue
Japan, US Target AI and Chips in $550 Billion Investment Push
Trump’s Arlington Arch Project Faces New Court Restrictions
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
US Sailor’s Father Detained by Immigration Authorities
FAA to Pause Reagan National Airport Flights for Freedom 250 IndyCar Race
France Keeps Top Health Alert as Officials Brace for Another Heatwave 



